[1]
|
Wang, G.L., Jiang, B.H., Rue, E.A. and Semenza, G.L. (1995) Hypoxia-Inducible Factor 1 Is a Basic-Helix-Loop-Helix-PAS Heterodimer Regulated by Cellular O2 Tension. Proceedings of the National Academy of Sciences of the United States of America, 92, 5510-5514. https://doi.org/10.1073/pnas.92.12.5510
|
[2]
|
Iyer, N.V., Kotch, L.E., Agani, F., et al. (1998) Cellular and Developmental Control of O2 Homeostasis by Hypoxia-Inducible Factor 1 Alpha. Genes & Development, 12, 149-162. https://doi.org/10.1101/gad.12.2.149
|
[3]
|
Semenza, G.L. (2003) Targeting HIF-1 for Cancer Therapy. Nature Reviews Cancer, 3, 721-732. https://doi.org/10.1038/nrc1187
|
[4]
|
Hogenesch, J.B., Chan, W.K., Jackiw, V.H., et al. (1997) Characterization of a Subset of the Basic-Helix-Loop-Helix-PAS Superfamily That Interacts with Components of the Dioxin Signaling Pathway. Journal of Biological Chemistry, 272, 8581-8593. https://doi.org/10.1074/jbc.272.13.8581
|
[5]
|
Iyer, N.V., Leung, S.W. and Semenza, G.L. (1998) The Human Hypoxia-Inducible Factor 1alpha Gene: HIF1A Structure and Evolutionary Conservation. Genomics, 52, 159-165. https://doi.org/10.1006/geno.1998.5416
|
[6]
|
Semenza, G.L. (1999) Regulation of Mammalian O2 Homeostasis by Hypoxia-Inducible Factor 1. Annual Review of Cell and Developmental Biology, 15, 551-578. https://doi.org/10.1146/annurev.cellbio.15.1.551
|
[7]
|
Semenza, G.L. (2000) HIF-1: Mediator of Physiological and Pathophysiological Responses to Hypoxia. Journal of Applied Physiology (1985), 88, 1474-1480. https://doi.org/10.1152/jappl.2000.88.4.1474
|
[8]
|
Semenza, G.L. (2002) HIF-1 and Tumor Progression: Pathophysiology and Therapeutics. Trends in Molecular Medicine, 8, S62-S67. https://doi.org/10.1016/S1471-4914(02)02317-1
|
[9]
|
Lee, J.W., Bae, S.H., Jeong, J.W., Kim, S.H. and Kim, K.W. (2004) Hypoxia-Inducible Factor (HIF-1) Alpha: Its Protein Stability and Biological Functions. Experimental & Molecular Medicine, 36, 1-12. https://doi.org/10.1038/emm.2004.1
|
[10]
|
Bruick, R.K. and McKnight, S.L. (2001) A Conserved Family of Prolyl-4-hydroxylases That Modify HIF. Science, 294, 1337-1340. https://doi.org/10.1126/science.1066373
|
[11]
|
Epstein, A.C., Gleadle, J.M., McNeill, L.A., et al. (2001) C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases That Regulate HIF by Prolyl Hydroxylation. Cell, 107, 43-54. https://doi.org/10.1016/S0092-8674(01)00507-4
|
[12]
|
Ivan, M., Kondo, K., Yang, H., et al. (2001) HIFalpha Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing. Science, 292, 464-468. https://doi.org/10.1126/science.1059817
|
[13]
|
Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., Gaskell, S.J., et al. (2001) Targeting of HIF-Alpha to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation. Science, 292, 468-472. https://doi.org/10.1126/science.1059796
|
[14]
|
Masson, N., Willam, C., Maxwell, P.H., Pugh, C.W. and Ratcliffe, P.J. (2001) Independent Function of Two Destruction Domains in Hypoxia-Inducible Factor-Alpha Chains Activated by Prolyl Hydroxylation. The EMBO Journal, 20, 5197-5206. https://doi.org/10.1093/emboj/20.18.5197
|
[15]
|
Huang, L.E., Arany, Z., Livingston, D.M. and Bunn, H.F. (1996) Activation of Hypoxia-Inducible Transcription Factor Depends Primarily upon Redox-Sensitive Stabilization of Its Alpha Subunit. Journal of Biological Chemistry, 271, 32253-32259. https://doi.org/10.1074/jbc.271.50.32253
|
[16]
|
Kallio, P.J., Pongratz, I., Gradin, K., McGuire, J. and Poellinger, L. (1997) Activation of Hypoxia-Inducible Factor 1alpha: Posttranscriptional Regulation and Conformational Change by Recruitment of the Arnt Transcription Factor. Proceedings of the National Academy of Sciences of the United States of America, 94, 5667-5672. https://doi.org/10.1073/pnas.94.11.5667
|
[17]
|
Jewell, U.R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R.H. and Gassmann, M. (2001) Induction of HIF-1alpha in Response to Hypoxia Is Instantaneous. The FASEB Journal, 15, 1312-1314. https://doi.org/10.1096/fj.00-0732fje
|
[18]
|
Hon, W.C., Wilson, M.I., Harlos, K., Claridge, T.D., Schofield, C.J., Pugh, C.W., et al. (2002) Structural Basis for the Recognition of Hydroxyproline in HIF-1 Alpha by pVHL. Nature, 417, 975-978. https://doi.org/10.1038/nature00767
|
[19]
|
Min, J.H., Yang, H., Ivan, M., Gertler, F., Kaelin, W.G. and Pavletich, N.P. (2002) Structure of an HIF-1alpha-pVHL Complex: Hydroxyproline Recognition in Signaling. Science, 296, 1886-1889. https://doi.org/10.1126/science.1073440
|
[20]
|
Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J. and Whitelaw, M.L. (2002) Asparagine Hydroxylation of the HIF Transactivation Domain a Hypoxic Switch. Science, 295, 858-861. https://doi.org/10.1126/science.1068592
|
[21]
|
Sang, N., Fang, J., Srinivas, V., Leshchinsky, I. and Caro, J. (2002) Carboxyl-Terminal Transactivation Activity of Hypoxia-Inducible Factor 1 Alpha Is Governed by a von Hippel-Lindau Protein-Independent, Hydroxylation-Regulated Association with p300/CBP. Molecular and Cellular Biology, 22, 2984-2992. https://doi.org/10.1128/MCB.22.9.2984-2992.2002
|
[22]
|
Munkacsy, G., Sztupinszki, Z., Herman, P., Ban, B., Penzvalto, Z., Szarvas, N. and Gyorffy, B. (2016) Validation of RNAi Silencing Efficiency Using Gene Array Data Shows 18.5% Failure Rate across 429 Independent Experiments. Molecular Therapy—Nucleic Acids, 5, e366. https://doi.org/10.1038/mtna.2016.66
|
[23]
|
Bracken, C.P., Whitelaw, M.L. and Peet, D.J. (2003) The Hypoxia-Inducible Factors: Key Transcriptional Regulators of Hypoxic Responses. Cellular and Molecular Life Sciences, 60, 1376-1393. https://doi.org/10.1007/s00018-003-2370-y
|
[24]
|
Wang, G.L. and Semenza, G.L. (1993) General Involvement of Hypoxia-Inducible Factor 1 in Transcriptional Response to Hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 90, 4304-4308. https://doi.org/10.1073/pnas.90.9.4304
|
[25]
|
Semenza, G.L. and Wang, G.L. (1992) A Nuclear Factor Induced by Hypoxia via de Novo Protein Synthesis Binds to the Human Erythropoietin Gene Enhancer at a Site Required for Transcriptional Activation. Molecular and Cellular Biology, 12, 5447-5454. https://doi.org/10.1128/MCB.12.12.5447
|
[26]
|
Lowell, B.B. and Shulman, G.I. (2005) Mitochondrial Dysfunction and Type 2 Diabetes. Science, 307, 384-387. https://doi.org/10.1126/science.1104343
|
[27]
|
Ryan, H.E., Lo, J. and Johnson, R.S. (1998) HIF-1 Alpha Is Required for Solid Tumor Formation and Embryonic Vascularization. The EMBO Journal, 17, 3005-3015. https://doi.org/10.1093/emboj/17.11.3005
|
[28]
|
Semenza, G.L., Shimoda, L.A. and Prabhakar, N.R. (2006) Regulation of Gene Expression by HIF-1. Signalling Pathways in Acute Oxygen Sensing: Novartis Foundation Symposium, Volume 272, 2-8. https://doi.org/10.1002/9780470035009.ch2
|
[29]
|
Ruas, J.L. and Poellinger, L. (2005) Hypoxia-Dependent Activation of HIF into a Transcriptional Regulator. Seminars in Cell & Developmental Biology, 16, 514-522. https://doi.org/10.1016/j.semcdb.2005.04.001
|
[30]
|
Schofield, C.J. and Ratcliffe, P.J. (2004) Oxygen Sensing by HIF Hydroxylases. Nature Reviews Molecular Cell Biology, 5, 343-354. https://doi.org/10.1038/nrm1366
|
[31]
|
Triantafyllou, A., Liakos, P., Tsakalof, A., Georgatsou, E., Simos, G. and Bonanou, S. (2006) Cobalt Induces Hypoxia-Inducible Factor-1alpha (HIF-1alpha) in HeLa Cells by an Iron-Independent, but ROS-, PI-3K- and MAPK-Dependent Mechanism. Free Radical Research, 40, 847-856. https://doi.org/10.1080/10715760600730810
|
[32]
|
Bilton, R.L. and Booker, G.W. (2003) The Subtle Side to Hypoxia Inducible Factor (HIFalpha) Regulation. European Journal of Biochemistry, 270, 791-798. https://doi.org/10.1046/j.1432-1033.2003.03446.x
|
[33]
|
Zagorska, A. and Dulak, J. (2004) HIF-1: The Knowns and Unknowns of Hypoxia Sensing. Acta Biochimica Polonica, 51, 563-585. https://doi.org/10.18388/abp.2004_3545
|
[34]
|
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R.C. and Conaway, J.W. (2000) Activation of HIF1alpha Ubiquitination by a Reconstituted von Hippel-Lindau (VHL) Tumor Suppressor Complex. Proceedings of the National Academy of Sciences of the United States of America, 97, 10430-10435. https://doi.org/10.1073/pnas.190332597
|
[35]
|
Wang, G.L. and Semenza, G.L. (1993) Desferrioxamine Induces Erythropoietin Gene Expression and Hypoxia-Inducible Factor 1 DNA-Binding Activity: Implications for Models of Hypoxia Signal Transduction. Blood, 82, 3610-3615. https://doi.org/10.1182/blood.V82.12.3610.3610
|
[36]
|
Yuan, Y., Hilliard, G., Ferguson, T. and Millhorn, D.E. (2003) Cobalt Inhibits the Interaction between Hypoxia-Inducible Factor-Alpha and von Hippel-Lindau Protein by Direct Binding to Hypoxia-Inducible Factor-Alpha. Journal of Biological Chemistry, 278, 15911-15916. https://doi.org/10.1074/jbc.M300463200
|
[37]
|
Haase, V.H. (2017) HIF-Prolyl Hydroxylases as Therapeutic Targets in Erythropoiesis and Iron Metabolism. Hemodialysis International, 21, S110-S124. https://doi.org/10.1111/hdi.12567
|
[38]
|
Gunton, J.E. (2020) Hypoxia-Inducible Factors and Diabetes. Journal of Clinical Investigation, 130, 5063-5073. https://doi.org/10.1172/JCI137556
|
[39]
|
Cho, N.H., Shaw, J.E., Karuranga, S., Huang, Y., da Rocha Fernandes, J.D., Ohlrogge, A.W. and Malanda, B. (2018) IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045. Diabetes Research and Clinical Practice, 138, 271-281. https://doi.org/10.1016/j.diabres.2018.02.023
|
[40]
|
Gregg, E.W., Sattar, N. and Ali, M.K. (2016) The Changing Face of Diabetes Complications. The Lancet Diabetes & Endocrinology, 4, 537-547. https://doi.org/10.1016/S2213-8587(16)30010-9
|
[41]
|
Roglic, G. and Unwin, N. (2010) Mortality Attributable to Diabetes: Estimates for the Year 2010. Diabetes Research and Clinical Practice, 87, 15-19. https://doi.org/10.1016/j.diabres.2009.10.006
|
[42]
|
Thong, F.S., Dugani, C.B. and Klip, A. (2005) Turning Signals on and off: GLUT4 Traffic in the Insulin-Signaling Highway. Physiology (Bethesda), 20, 271-284. https://doi.org/10.1152/physiol.00017.2005
|
[43]
|
Huang, S. and Czech, M.P. (2007) The GLUT4 Glucose Transporter. Cell Metabolism, 5, 237-252. https://doi.org/10.1016/j.cmet.2007.03.006
|
[44]
|
Klip, A., McGraw, T.E. and James, D.E. (2019) Thirty Sweet Years of GLUT4. Journal of Biological Chemistry, 294, 11369-11381. https://doi.org/10.1074/jbc.REV119.008351
|
[45]
|
Knip, M. and Siljander, H. (2008) Autoimmune Mechanisms in Type 1 Diabetes. Autoimmunity Reviews, 7, 550-557. https://doi.org/10.1016/j.autrev.2008.04.008
|
[46]
|
Bach, J.F. (1994) Insulin-Dependent Diabetes Mellitus as an Autoimmune Disease. Endocrine Reviews, 15, 516-542. https://doi.org/10.1210/edrv-15-4-516
|
[47]
|
Fourlanos, S., Narendran, P., Byrnes, G.B., Colman, P.G. and Harrison, L.C. (2004) Insulin Resistance Is a Risk Factor for Progression to Type 1 Diabetes. Diabetologia, 47, 1661-1667. https://doi.org/10.1007/s00125-004-1507-3
|
[48]
|
Kahn, S.E., Hull, R.L. and Utzschneider, K.M. (2006) Mechanisms Linking Obesity to Insulin Resistance and Type 2 Diabetes. Nature, 444, 840-846. https://doi.org/10.1038/nature05482
|
[49]
|
Seidell, J.C. (2000) Obesity, Insulin Resistance and Diabetes—A Worldwide Epidemic. British Journal of Nutrition, 83, S5-S8. https://doi.org/10.1017/S000711450000088X
|
[50]
|
Kasuga, M. (2006) Insulin Resistance and Pancreatic Beta Cell Failure. Journal of Clinical Investigation, 116, 1756-1760. https://doi.org/10.1172/JCI29189
|
[51]
|
Gunton, J.E., Kulkarni, R.N., Yim, S., Okada, T., Hawthorne, W.J., Tseng, Y.H., Roberson, R.S., et al. (2005) Loss of ARNT/HIF1beta Mediates Altered Gene Expression and Pancreatic-Islet Dysfunction in Human Type 2 Diabetes. Cell, 122, 337-349. https://doi.org/10.1016/j.cell.2005.05.027
|
[52]
|
Levisetti, M.G. and Olonsky, K.S. (2005) Diabetic Pancreatic Beta Cells ARNT All They Should Be. Cell Metabolism, 2, 78-80. https://doi.org/10.1016/j.cmet.2005.07.005
|
[53]
|
Cheng, K., Ho, K., Stokes, R., Scott, C., Lau, S.M., Hawthorne, W.J., et al. (2010) Hypoxia-Inducible Factor-1alpha Regulates Beta Cell Function in Mouse and Human Islets. Journal of Clinical Investigation, 120, 2171-2183. https://doi.org/10.1172/JCI35846
|
[54]
|
Stokes, R.A., Cheng, K., Deters, N., Lau, S.M., Hawthorne, W.J., O’Connell, P.J., Stolp, J., et al. (2013) Hypoxia-Inducible Factor-1alpha (HIF-1alpha) Potentiates Beta-Cell Survival after Islet Transplantation of Human and Mouse Islets. Cell Transplantation, 22, 253-266. https://doi.org/10.3727/096368912X647180
|
[55]
|
Cheng, K. andrikopoulos, S. and Gunton, J.E. (2013) First Phase Insulin Secretion and Type 2 Diabetes. Current Molecular Medicine, 13, 126-139. https://doi.org/10.2174/156652413804486287
|
[56]
|
Davies, M.J., Rayman, G., Grenfell, A., Gray, I.P., Day, J.L. and Hales, C.N. (1994) Loss of the First Phase Insulin Response to Intravenous Glucose in Subjects with Persistent Impaired Glucose Tolerance. Diabetic Medicine, 11, 432-436. https://doi.org/10.1111/j.1464-5491.1994.tb00302.x
|
[57]
|
Weir, G.C. and Bonner-Weir, S. (2004) Five Stages of Evolving Beta-Cell Dysfunction during Progression to Diabetes. Diabetes, 53, S16-S21. https://doi.org/10.2337/diabetes.53.suppl_3.S16
|
[58]
|
Colman, P.G., McNair, P., Margetts, H., Schmidli, R.S., Werther, G.A., Alford, F.P., et al. (1998) The Melbourne Pre-Diabetes Study: Prediction of Type 1 Diabetes Mellitus Using Antibody and Metabolic Testing. The Medical Journal of Australia, 169, 81-84. https://doi.org/10.5694/j.1326-5377.1998.tb140188.x
|
[59]
|
Lalwani, A., Warren, J., Liuwantara, D., Hawthorne, W.J., O’Connell, P.J., Gonzalez, F.J., et al. (2019) Beta Cell Hypoxia-Inducible Factor-1alpha Is Required for the Prevention of Type 1 Diabetes. Cell Reports, 27, 2370-2384e6. https://doi.org/10.1016/j.celrep.2019.04.086
|
[60]
|
Hewitson, K.S., Lienard, B.M., McDonough, M.A., Clifton, I.J., Butler, D., Soares, A.S., et al. (2007) Structural and Mechanistic Studies on the Inhibition of the Hypoxia-Inducible Transcription Factor Hydroxylases by Tricarboxylic Acid Cycle Intermediates. Journal of Biological Chemistry, 282, 3293-3301. https://doi.org/10.1074/jbc.M608337200
|
[61]
|
Weidemann, A. and Johnson, R.S. (2008) Biology of HIF-1alpha. Cell Death & Differentiation, 15, 621-627. https://doi.org/10.1038/cdd.2008.12
|
[62]
|
Catrina, S.B., Okamoto, K., Pereira, T., Brismar, K. and Poellinger, L. (2004) Hyperglycemia Regulates Hypoxia-Inducible Factor-1alpha Protein Stability and Function. Diabetes, 53, 3226-3232. https://doi.org/10.2337/diabetes.53.12.3226
|
[63]
|
Bento, C.F. and Pereira, P. (2011) Regulation of Hypoxia-Inducible Factor 1 and the Loss of the Cellular Response to Hypoxia in Diabetes. Diabetologia, 54, 1946-1956. https://doi.org/10.1007/s00125-011-2191-8
|
[64]
|
Dodd, M.S., Sousa Fialho, M.D.L., Montes Aparicio, C.N., Kerr, M., Timm, K.N., Griffin, J.L., et al. (2018) Fatty Acids Prevent Hypoxia-Inducible Factor-1alpha Signaling through Decreased Succinate in Diabetes. JACC: Basic to Translational Science, 3, 485-498. https://doi.org/10.1016/j.jacbts.2018.04.005
|
[65]
|
Pessin, J.E. and Saltiel, A.R. (2000) Signaling Pathways in Insulin Action: Molecular Targets of Insulin Resistance. Journal of Clinical Investigation, 106, 165-169. https://doi.org/10.1172/JCI10582
|
[66]
|
Sell, H., Dietze-Schroeder, D. and Eckel, J. (2006) The Adipocyte-Myocyte Axis in Insulin Resistance. Trends in Endocrinology and Metabolism, 17, 416-422. https://doi.org/10.1016/j.tem.2006.10.010
|
[67]
|
Gorgens, S.W., Benninghoff, T., Eckardt, K., Springer, C., Chadt, A., Melior, A., et al. (2017) Hypoxia in Combination with Muscle Contraction Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle via the HIF-1alpha Pathway. Diabetes, 66, 2800-2807. https://doi.org/10.2337/db16-1488
|
[68]
|
Lindholm, M.E. and Rundqvist, H. (2016) Skeletal Muscle Hypoxia-Inducible Factor-1 and Exercise. Experimental Physiology, 101, 28-32. https://doi.org/10.1113/EP085318
|
[69]
|
Favier, F.B., Britto, F.A., Freyssenet, D.G., Bigard, X.A. and Benoit, H. (2015) HIF-1-Driven Skeletal Muscle Adaptations to Chronic Hypoxia: Molecular Insights into Muscle Physiology. Cellular and Molecular Life Sciences, 72, 4681-4696. https://doi.org/10.1007/s00018-015-2025-9
|
[70]
|
Badin, P.M., Sopariwala, D.H., Lorca, S. and Narkar, V.A. (2016) Muscle Arnt/Hif1beta Is Dispensable in Myofiber Type Determination, Vascularization and Insulin Sensitivity. PLOS ONE, 11, e0168457. https://doi.org/10.1371/journal.pone.0168457
|
[71]
|
Sakagami, H., Makino, Y., Mizumoto, K., Isoe, T., Takeda, Y., Watanabe, J., et al. (2014) Loss of HIF-1alpha Impairs GLUT4 Translocation and Glucose Uptake by the Skeletal Muscle Cells. The American Journal of Physiology—Endocrinology and Metabolism, 306, E1065-E1076. https://doi.org/10.1152/ajpendo.00597.2012
|
[72]
|
Mason, S.D., Howlett, R.A., Kim, M.J., Olfert, I.M., Hogan, M.C., McNulty, W., et al. (2004) Loss of Skeletal Muscle HIF-1alpha Results in Altered Exercise Endurance. PLOS Biology, 2, e288. https://doi.org/10.1371/journal.pbio.0020288
|
[73]
|
Sinha, K.M., Tseng, C., Guo, P., Lu, A., Pan, H., Gao, X. andrews, R., Eltzschig, H. and Huard, J. (2019) Hypoxia-Inducible Factor 1alpha (HIF-1alpha) Is a Major Determinant in the Enhanced Function of Muscle-Derived Progenitors from MRL/MpJ Mice. The FASEB Journal, 33, 8321-8334. https://doi.org/10.1096/fj.201801794R
|
[74]
|
Billin, A.N., Honeycutt, S.E., McDougal, A.V., Kerr, J.P., Chen, Z., Freudenberg, J.M., et al. (2018) HIF Prolyl Hydroxylase Inhibition Protects Skeletal Muscle from Eccentric Contraction-Induced Injury. Skeletal Muscle, 8, 35. https://doi.org/10.1186/s13395-018-0179-5
|
[75]
|
Sinha, I., Sakthivel, D., Olenchock, B.A., Kruse, C.R., Williams, J., Varon, D.E., Smith, J.D., et al. (2017) Prolyl Hydroxylase Domain-2 Inhibition Improves Skeletal Muscle Regeneration in a Male Murine Model of Obesity. Frontiers in Endocrinology (Lausanne), 8, Article No. 153. https://doi.org/10.3389/fendo.2017.00153
|
[76]
|
Doring, F., Onur, S., Fischer, A., Boulay, M.R., Perusse, L., Rankinen, T., Rauramaa, R., Wolfarth, B. and Bouchard, C. (2010) A Common Haplotype and the Pro582Ser Polymorphism of the Hypoxia-Inducible Factor-1alpha (HIF1A) Gene in Elite Endurance Athletes. Journal of Applied Physiology (1985), 108, 1497-1500. https://doi.org/10.1152/japplphysiol.01165.2009
|
[77]
|
Sim, J., Cowburn, A.S., Palazon, A., Madhu, B., Tyrakis, P.A., Macias, D., Bargiela, D.M., et al. (2018) The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia. Cell Metabolism, 27, 898-913e7. https://doi.org/10.1016/j.cmet.2018.02.020
|
[78]
|
Sun, K., Tordjman, J., Clement, K. and Scherer, P.E. (2013) Fibrosis and Adipose Tissue Dysfunction. Cell Metabolism, 18, 470-477. https://doi.org/10.1016/j.cmet.2013.06.016
|
[79]
|
Guglielmi, V., Cardellini, M., Cinti, F., Corgosinho, F., Cardolini, I., D’Adamo, M., Zingaretti, M.C., et al. (2015) Omental Adipose Tissue Fibrosis and Insulin Resistance in Severe Obesity. Nutrition & Diabetes, 5, e175. https://doi.org/10.1038/nutd.2015.22
|
[80]
|
Halberg, N., Khan, T., Trujillo, M.E., Wernstedt-Asterholm, I., Attie, A.D., Sherwani, S., Wang, Z.V., et al. (2009) Hypoxia-Inducible Factor 1alpha Induces Fibrosis and Insulin Resistance in White Adipose Tissue. Molecular and Cellular Biology, 29, 4467-4483. https://doi.org/10.1128/MCB.00192-09
|
[81]
|
Sun, K., Halberg, N., Khan, M., Magalang, U.J. and Scherer, P.E. (2013) Selective Inhibition of Hypoxia-Inducible Factor 1alpha Ameliorates Adipose Tissue Dysfunction. Molecular and Cellular Biology, 33, 904-917. https://doi.org/10.1128/MCB.00951-12
|
[82]
|
Zhang, X., Lam, K.S.L., Ye, H., Chung, S.K., Zhou, M., Wang, Y. and Xu, A. (2010) Adipose Tissue-Specific Inhibition of Hypoxia-Inducible Factor 1{alpha} Induces Obesity and Glucose Intolerance by Impeding Energy Expenditure in Mice. Journal of Biological Chemistry, 285, 32869-32877. https://doi.org/10.1074/jbc.M110.135509
|
[83]
|
Jiang, C., Qu, A., Matsubara, T., Chanturiya, T., Jou, W., Gavrilova, O., Shah, Y.M. and Gonzalez, F.J. (2011) Disruption of Hypoxia-Inducible Factor 1 in Adipocytes Improves Insulin Sensitivity and Decreases Adiposity in High-Fat Diet-Fed Mice. Diabetes, 60, 2484-2495. https://doi.org/10.2337/db11-0174
|
[84]
|
Zhang, J., Wang, Y., Gao, Z., Yun, Z. and Ye, J. (2012) Hypoxia-Inducible Factor 1 Activation from Adipose Protein 2-cre Mediated Knockout of von Hippel-Lindau Gene Leads to Embryonic Lethality. Clinical and Experimental Pharmacology and Physiology, 39, 145-150. https://doi.org/10.1111/j.1440-1681.2011.05656.x
|
[85]
|
Lee, Y.S., Kim, J.W., Osborne, O., Oh, D.Y., Sasik, R., Schenk, S., Chen, A., et al. (2014) Increased Adipocyte O2 Consumption Triggers HIF-1alpha, Causing Inflammation and Insulin Resistance in Obesity. Cell, 157, 1339-1352. https://doi.org/10.1016/j.cell.2014.05.012
|
[86]
|
Duscher, D., Neofytou, E., Wong, V.W., Maan, Z.N., Rennert, R.C., Inayathullah, M., et al. (2015) Transdermal Deferoxamine Prevents Pressure-Induced Diabetic Ulcers. Proceedings of the National Academy of Sciences of the United States of America, 112, 94-99. https://doi.org/10.1073/pnas.1413445112
|
[87]
|
Zhu, Y., Wang, Y., Jia, Y., Xu, J. and Chai, Y. (2019) Roxadustat Promotes Angiogenesis through HIF-1alpha/VEGF/VEGFR2 Signaling and Accelerates Cutaneous Wound Healing in Diabetic Rats. Wound Repair and Regeneration, 27, 324-334. https://doi.org/10.1111/wrr.12708
|
[88]
|
Persson, P. and Palm, F. (2017) Hypoxia-Inducible Factor Activation in Diabetic Kidney Disease. Current Opinion in Nephrology and Hypertension, 26, 345-350. https://doi.org/10.1097/MNH.0000000000000341
|
[89]
|
Sugahara, M., Tanaka, S., Tanaka, T., Saito, H., Ishimoto, Y., Wakashima, T., Ueda, M., et al. (2020) Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice. Journal of the American Society of Nephrology, 31, 560-577. https://doi.org/10.1681/ASN.2019060582
|
[90]
|
Rahtu-Korpela, L., Maatta, J., Dimova, E.Y., Horkko, S., Gylling, H., Walkinshaw, G., Hakkola, J., et al. (2016) Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects against Development of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 36, 608-617. https://doi.org/10.1161/ATVBAHA.115.307136
|
[91]
|
Hyvarinen, J., Hassinen, I.E., Sormunen, R., Maki, J.M., Kivirikko, K.I., Koivunen, P. and Myllyharju, J. (2010) Hearts of Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Hypomorphic Mice Show Protection against Acute Ischemia-Reperfusion Injury. Journal of Biological Chemistry, 285, 13646-13657. https://doi.org/10.1074/jbc.M109.084855
|
[92]
|
Rojas, D.R., Tegeder, I., Kuner, R. and Agarwal, N. (2018) Hypoxia-Inducible Factor 1alpha Protects Peripheral Sensory Neurons from Diabetic Peripheral Neuropathy by Suppressing Accumulation of Reactive Oxygen Species. Journal of Molecular Medicine (Berlin), 96, 1395-1405. https://doi.org/10.1007/s00109-018-1707-9
|
[93]
|
Zeinivand, M., Nahavandi, A. and Zare, M. (2020) Deferoxamine Regulates Neuroinflammation and Oxidative Stress in Rats with Diabetes-Induced Cognitive Dysfunction. Inflammopharmacology, 28, 575-583. https://doi.org/10.1007/s10787-019-00665-7
|
[94]
|
Rahtu-Korpela, L., Karsikas, S., Horkko, S., Blanco Sequeiros, R., Lammentausta, E., Makela, K.A., Herzig, K.H., et al. (2014) HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects against Obesity and Metabolic Dysfunction. Diabetes, 63, 3324-3333. https://doi.org/10.2337/db14-0472
|
[95]
|
Michailidou, Z., Morton, N.M., Moreno Navarrete, J.M., West, C.C., Stewart, K.J., Fernandez-Real, J.M., Schofield, C.J., Seckl, J.R. and Ratcliffe, P.J. (2015) Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion. Diabetes, 64, 733-745. https://doi.org/10.2337/db14-0233
|
[96]
|
Dhillon, S. (2019) Roxadustat: First Global Approval. Drugs, 79, 563-572. https://doi.org/10.1007/s40265-019-01077-1
|
[97]
|
Smith, K.A., Waypa, G.B. and Schumacker, P.T. (2017) Redox Signaling during Hypoxia in Mammalian Cells. Redox Biology, 13, 228-234. https://doi.org/10.1016/j.redox.2017.05.020
|
[98]
|
Fuhrmann, D.C. and Brune, B. (2017) Mitochondrial Composition and Function under the Control of Hypoxia. Redox Biology, 12, 208-215. https://doi.org/10.1016/j.redox.2017.02.012
|
[99]
|
Schofield, C.J. and Ratcliffe, P.J. (2005) Signalling Hypoxia by HIF Hydroxylases. Biochemical and Biophysical Research Communications, 338, 617-626. https://doi.org/10.1016/j.bbrc.2005.08.111
|
[100]
|
Semenza, G.L. (2012) Hypoxia-Inducible Factors in Physiology and Medicine. Cell, 148, 399-408. https://doi.org/10.1016/j.cell.2012.01.021
|
[101]
|
Brand, M.D., Affourtit, C., Esteves, T.C., Green, K., Lambert, A.J., Miwa, S., Pakay, J.L. and Parker, N. (2004) Mitochondrial Superoxide: Production, Biological Effects, and Activation of Uncoupling Proteins. Free Radical Biology and Medicine, 37, 755-767. https://doi.org/10.1016/j.freeradbiomed.2004.05.034
|
[102]
|
Semenza, G.L. (2011) Hypoxia-Inducible Factor 1: Regulator of Mitochondrial Metabolism and Mediator of Ischemic Preconditioning. Biochimica et Biophysica Acta, 1813, 1263-1268. https://doi.org/10.1016/j.bbamcr.2010.08.006
|
[103]
|
Chan, S.Y., Zhang, Y.Y., Hemann, C., Mahoney, C.E., Zweier, J.L. and Loscalzo, J. (2009) MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2. Cell Metabolism, 10, 273-284. https://doi.org/10.1016/j.cmet.2009.08.015
|
[104]
|
Semenza, G.L. (2010) HIF-1: Upstream and Downstream of Cancer Metabolism. Current Opinion in Genetics and Development, 20, 51-56. https://doi.org/10.1016/j.gde.2009.10.009
|
[105]
|
Zhang, H., Bosch-Marce, M., Shimoda, L.A., Tan, Y.S., Baek, J.H., Wesley, J.B., Gonzalez, F.J. and Semenza, G.L. (2008) Mitochondrial Autophagy Is an HIF-1-Dependent Adaptive Metabolic Response to Hypoxia. Journal of Biological Chemistry, 283, 10892-10903. https://doi.org/10.1074/jbc.M800102200
|
[106]
|
Briston, T., Yang, J. and Ashcroft, M. (2011) HIF-1alpha Localization with Mitochondria: A New Role for an Old Favorite? Cell Cycle, 10, 4170-4171. https://doi.org/10.4161/cc.10.23.18565
|
[107]
|
Li, J., Qian, X., Hu, J. and Sha, B. (2009) Molecular Chaperone Hsp70/Hsp90 Prepares the Mitochondrial Outer Membrane Translocon Receptor Tom71 for Preprotein Loading. Journal of Biological Chemistry, 284, 23852-23859. https://doi.org/10.1074/jbc.M109.023986
|
[108]
|
Li, H.S., Zhou, Y.N., Li, L., Li, S.F., Long, D., Chen, X.L., Zhang, J.B., Feng, L. and Li, Y.P. (2019) HIF-1alpha Protects against Oxidative Stress by Directly Targeting Mitochondria. Redox Biology, 25, Article ID: 101109. https://doi.org/10.1016/j.redox.2019.101109
|
[109]
|
Ye, J. (2009) Emerging Role of Adipose Tissue Hypoxia in Obesity and Insulin Resistance. International Journal of Obesity (London), 33, 54-66. https://doi.org/10.1038/ijo.2008.229
|
[110]
|
Trayhurn, P., Wang, B. and Wood, I.S. (2008) Hypoxia in Adipose Tissue: A Basis for the Dysregulation of Tissue Function in Obesity? British Journal of Nutrition, 100, 227-235. https://doi.org/10.1017/S0007114508971282
|
[111]
|
Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., et al. (2007) Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation. Diabetes, 56, 901-911. https://doi.org/10.2337/db06-0911
|
[112]
|
Rausch, M.E., Weisberg, S., Vardhana, P. and Tortoriello, D.V. (2008) Obesity in C57BL/6J Mice Is Characterized by Adipose Tissue Hypoxia and Cytotoxic T-Cell Infiltration. International Journal of Obesity (London), 32, 451-463. https://doi.org/10.1038/sj.ijo.0803744
|
[113]
|
Ye, J., Gao, Z., Yin, J. and He, Q. (2007) Hypoxia Is a Potential Risk Factor for Chronic Inflammation and Adiponectin Reduction in Adipose Tissue of ob/ob and Dietary Obese Mice. The American Journal of Physiology—Endocrinology and Metabolism, 293, E1118-E1128. https://doi.org/10.1152/ajpendo.00435.2007
|
[114]
|
Semenza, G.L. (2000) HIF-1 and Human Disease: One Highly Involved Factor. Genes & Development, 14, 1983-1991. https://doi.org/10.1101/gad.14.16.1983
|
[115]
|
Arany, Z., Huang, L.E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M.A., Bunn, H.F. and Livingston, D.M. (1996) An Essential Role for p300/CBP in the Cellular Response to Hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 93, 12969-12973. https://doi.org/10.1073/pnas.93.23.12969
|
[116]
|
Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K., Poellinger, L. and Fujii-Kuriyama, Y. (1999) Molecular Mechanisms of Transcription Activation by HLF and HIF1alpha in Response to Hypoxia: Their Stabilization and Redox Signal-Induced Interaction with CBP/p300. The EMBO Journal, 18, 1905-1914. https://doi.org/10.1093/emboj/18.7.1905
|
[117]
|
Fath, D.M., Kong, X., Liang, D., Lin, Z., Chou, A., Jiang, Y., Fang, J., Caro, J. and Sang, N. (2006) Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-Inducible Factors Independently of Direct Acetylation of HIF-Alpha. Journal of Biological Chemistry, 281, 13612-13619. https://doi.org/10.1074/jbc.M600456200
|
[118]
|
Kato, H., Tamamizu-Kato, S. and Shibasaki, F. (2004) Histone Deacetylase 7 Associates with Hypoxia-Inducible Factor 1alpha and Increases Transcriptional Activity. Journal of Biological Chemistry, 279, 41966-41974. https://doi.org/10.1074/jbc.M406320200
|
[119]
|
Lim, J.H., Lee, Y.M., Chun, Y.S., Chen, J., Kim, J.E. and Park, J.W. (2010) Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1alpha. Molecular Cell, 38, 864-878. https://doi.org/10.1016/j.molcel.2010.05.023
|
[120]
|
Qian, D.Z., Kachhap, S.K., Collis, S.J., Verheul, H.M., Carducci, M.A., Atadja, P. and Pili, R. (2006) Class II Histone Deacetylases Are Associated with VHL-Independent Regulation of Hypoxia-Inducible Factor 1 Alpha. Cancer Research, 66, 8814-8821. https://doi.org/10.1158/0008-5472.CAN-05-4598
|
[121]
|
Cao, Y. (2010) Adipose Tissue Angiogenesis as a Therapeutic Target for Obesity and Metabolic Diseases. Nature Reviews Drug Discovery, 9, 107-115. https://doi.org/10.1038/nrd3055
|
[122]
|
Christiaens, V. and Lijnen, H.R. (2010) Angiogenesis and Development of Adipose Tissue. Molecular and Cellular Endocrinology, 318, 2-9. https://doi.org/10.1016/j.mce.2009.08.006
|
[123]
|
Crandall, D.L., Hausman, G.J. and Kral, J.G. (1997) A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives. Microcirculation, 4, 211-232. https://doi.org/10.3109/10739689709146786
|
[124]
|
Brakenhielm, E., Cao, R., Gao, B., Angelin, B., Cannon, B., Parini, P. and Cao, Y. (2004) Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice. Circulation Research, 94, 1579-1588. https://doi.org/10.1161/01.RES.0000132745.76882.70
|
[125]
|
Kim, D.H., Woods, S.C. and Seeley, R.J. (2010) Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body Weight. Diabetes, 59, 907-915. https://doi.org/10.2337/db09-1141
|
[126]
|
Fukumura, D., Ushiyama, A., Duda, D.G., Xu, L., Tam, J., Krishna, V., Chatterjee, K., Garkavtsev, I., Jain, R.K. (2003) Paracrine Regulation of Angiogenesis and Adipocyte Differentiation during in Vivo Adipogenesis. Circulation Research, 93, e88-e97. https://doi.org/10.1161/01.RES.0000099243.20096.FA
|
[127]
|
Claffey, K.P., Wilkison, W.O. and Spiegelman, B.M. (1992) Vascular Endothelial Growth Factor. Regulation by Cell Differentiation and Activated Second Messenger Pathways. Journal of Biological Chemistry, 267, 16317-16322. https://doi.org/10.1016/S0021-9258(18)42003-0
|
[128]
|
Miyazawa-Hoshimoto, S., Takahashi, K., Bujo, H., Hashimoto, N., Yagui, K. and Saito, Y. (2005) Roles of Degree of Fat Deposition and Its Localization on VEGF Expression in Adipocytes. The American Journal of Physiology—Endocrinology and Metabolism, 288, E1128-E1136. https://doi.org/10.1152/ajpendo.00003.2004
|
[129]
|
Zhang, Q.X., Magovern, C.J., Mack, C.A., Budenbender, K.T., Ko, W. and Rosengart, T.K. (1997) Vascular Endothelial Growth Factor Is the Major Angiogenic Factor in Omentum: Mechanism of the Omentum-Mediated Angiogenesis. Journal of Surgical Research, 67, 147-154. https://doi.org/10.1006/jsre.1996.4983
|
[130]
|
Raval, R.R., Lau, K.W., Tran, M.G., Sowter, H.M., Mandriota, S.J., Li, J.L., et al. (2005) Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma. Molecular and Cellular Biology, 25, 5675-5686. https://doi.org/10.1128/MCB.25.13.5675-5686.2005
|
[131]
|
Ellinghaus, P., Heisler, I., Unterschemmann, K., Haerter, M., Beck, H., Greschat, S., Ehrmann, A., et al. (2013) BAY 87-2243, a Highly Potent and Selective Inhibitor of Hypoxia-Induced Gene Activation Has Antitumor Activities by Inhibition of Mitochondrial Complex I. Cancer Medicine, 2, 611-624. https://doi.org/10.1002/cam4.112
|
[132]
|
Koh, M.Y., Spivak-Kroizman, T., Venturini, S., Welsh, S., Williams, R.R., Kirkpatrick, D.L. and Powis, G. (2008) Molecular Mechanisms for the Activity of PX-478, an Antitumor Inhibitor of the Hypoxia-Inducible Factor-1alpha. Molecular Cancer Therapeutics, 7, 90-100. https://doi.org/10.1158/1535-7163.MCT-07-0463
|
[133]
|
Yin, S., Kaluz, S., Devi, N.S., Jabbar, A.A., de Noronha, R.G., Mun, J., et al. (2012) Arylsulfonamide KCN1 Inhibits in vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1alpha Interaction with Cofactors p300/CBP. Clinical Cancer Research, 18, 6623-6633. https://doi.org/10.1158/1078-0432.CCR-12-0861
|